What’s Going On With Tempus AI Stock Monday?

Tempus AI, Inc. (NASDAQ:TEM) stock fell Monday as Ambry Genetics, a wholly owned subsidiary of Tempus AI, announced the completion of its one-millionth deoxyribonucleic acid (DNA)/ ribonucleic acid (RNA) test, highlighting growing adoption of DNA and RNA-informed...